Intermediate‑Acting Insulin: Types, Action Profile, and Clinical Use
Intermediate‑acting insulins have onset ~1–2 hrs, peak 4–12 hrs, duration 12–18+ hrs. Used as basal component in split‑mixed regimens.
Types
- NPH (Neutral Protamine Hagedorn): Human insulin + protamine + zinc → suspension. Cloudy. Must resuspend (roll/invert) before each dose. Peak ~4–10 hrs.
- Lente (discontinued in US): Insulin + zinc (no protamine). Longer, flatter than NPH. Replaced by basal analogs.
Modern Context
- Basal analogs (glargine U100/U300, detemir, degludec) have largely replaced NPH: flatter profile, less hypoglycemia, once‑daily (or q12h detemir), no resuspension.
- NPH remains cost‑effective (vial ~$25 vs. $300+ for analogs) and is used in resource‑limited settings or mixed regimens.
Clinical Pearls
- NPH given at bedtime covers overnight/dawn; morning dose covers afternoon.
- Hypoglycemia risk highest at peak (night for bedtime dose).
- Mixing: NPH + regular/rapid analog in same syringe (draw rapid first). Do not mix with other basal analogs.
- Rotation of injection sites prevents lipohypertrophy (impairs absorption).
Individualize regimen with diabetes team. Time‑in‑range >70% is the goal.
Diabetes - Related Articles
- Manage Blood Sugar: Strategies to Achieve Levels Below 200
- Understanding Diabetic Nerve Pain: Symptoms & Causes
- Type 2 Diabetes and Heart Disease: Understanding the Link and Reducing Your Risk
- Insulin Pump Guide: Comfortable & Discreet Wear - Diabetes Management
- Understanding Type 1 Diabetes: Causes, Symptoms & Risk Factors
- Choosing the Right Diabetes Education Program: A Comprehensive Guide
- Understanding HbA1c Levels: A Comprehensive Guide for Diabetes Management
